A new moment for facing dengue?
- PMID: 25710851
- PMCID: PMC4445291
- DOI: 10.1179/2047772415Z.000000000247
A new moment for facing dengue?
Comment on
-
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.Lancet. 2014 Oct 11;384(9951):1358-65. doi: 10.1016/S0140-6736(14)61060-6. Epub 2014 Jul 10. Lancet. 2014. PMID: 25018116 Clinical Trial.
-
Efficacy of a tetravalent dengue vaccine in children in Latin America.N Engl J Med. 2015 Jan 8;372(2):113-23. doi: 10.1056/NEJMoa1411037. Epub 2014 Nov 3. N Engl J Med. 2015. PMID: 25365753 Clinical Trial.
References
-
- Capeding MR, Tran NH, Hadinegoro SR, Ismail HIM, Chotpitayasunondh T, Chua MN et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial The Lancet. 2014;384:1358–65. - PubMed
-
- Villar L, Dayan GH, Arredondo-Garcia JL, Rivera DM, Cunha R, Deseda C et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. The New Eng J Med. 2014 - PubMed
-
- Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba Set al.Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial The Lancet 2012;1–9. - PubMed
-
- WHO. Global strategy for dengue prevention and control.: World Health Organization; 2012. ISBN 978 92 4 150403 4.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical